Real-world prevalence of homologous recombination repair gene (BRCA1/2 and ATM) mutations (HRRm) in patients (pts) with advanced prostate cancer (aPC) as detected by comprehensive genomic profiling (CGP) of circulating cell-free DNA (cfDNA).

Authors

null

Nicolas Sayegh

Huntsman Cancer Institute - University of Utah Health Care, Salt Lake City, UT

Nicolas Sayegh , Umang Swami , Pedro C. Barata , Michael B. Lilly , Roberto Nussenzveig , Chuck Hensel , Alan Haruo Bryce , Mehmet Asim Bilen , Elisabeth I. Heath , Lakshminarayanan Nandagopal , Rohan Garje , Philip James Saylor , Hani M. Babiker , Daniel A. Vaena , Manish Kohli , Sumanta K. Pal , A. Oliver Sartor , Neeraj Agarwal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Prostate Cancer - Localized Disease

Track

Prostate Cancer - Localized

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 256)

DOI

10.1200/JCO.2021.39.6_suppl.256

Abstract #

256

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Laura Graham

First Author: Leslie A. Bucheit

First Author: Syed Arsalan Ahmed Naqvi